Hui Lian

No ORCID on file · 3 papers in corpus
other 2022
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2022/5929694

OBJECTIVE: To explore the pharmacological mechanism of a Chinese patent drug (Kunling Pill (KLP)) on improving diminished ovarian reserve based on proteomic analysis. METHODS: A total of 18 patients divided into three groups (the normal ov…

lab-animal 2020
Oncology letters ·doi:10.3892/ol.2020.12254

Osteosarcoma is a common primary bone cancer that there are currently no effective treatment strategies for. Forkhead box M1 (FoxM1) is key in the development of osteosarcoma, and microRNA (miR)-216b serves an antitumor role by targeting Fo…

meta-analysis 2015
International journal of environmental research and public health ·doi:10.3390/ijerph121012924

BACKGROUND: Long time exposure to particular matter has been linked to myocardial infarction, stroke and blood pressure, but its association with atherosclerosis is not clear. This meta-analysis was aimed at assessing whether PM₂.₅ and PM₁₀…